About - CVS :

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Employees - 219000, CEO - Mr. J. David Joyner CEBS, Sector - Healthcare, Country - US, Market Cap - 56.56B

Altman ZScore(max is 10): 2.03, Piotroski Score(max is 10): 5, Working Capital: $-17284000000, Total Assets: $252427000000, Retained Earnings: $62038000000, EBIT: 9617000000, Total Liabilities: $177321000000, Revenue: $368912000000

- Current Price $44.36 - Analyst Target Price $64.55

Stats & Key Metrics
TickerCVS
IndexS&P 500
Curent Price 44.36
Change1.32%
Market Cap56.56B
Average Volume13.74M
Income5.02B
Sales369.15B
Book Value/Share59.57
Cash/Share7.64
Dividend Est2.52 (5.68%)
Dividend TTM2.66 (6.00%)
Dividend Ex-DateOct 21, 2024
Employees300000
Moving Avg 20days-17.19%
Moving Avg 50days-21.03%
Moving Avg 200days-27.05%
Shares Outstanding1.26B
Earnings DateNov 06 BMO
Inst. Ownership82.23%
Key Ratios & Margins
Price/Earnings11.27
Forwad P/E7.30
PE Growth-
Price/Sales0.15
Price/Book0.74
Price/Cash5.80
Price/FCF33.53
Quick Ratio0.59
Current Ratio0.80
Debt/Equity1.10
Return on Assets1.99%
Return on Equity6.72%
Return on Investment3.34%
Gross Margin14.25%
Ops Margin3.10%
Profit Margin1.36%
RSI27.04
BETA(β)0.58
From 52week Low1.74%
From 52week High-46.71%
Earnings & Valuation
EPS3.94
EPS next Year6.08
EPS next Qtr1.00
EPS this Year-39.44%
EPS next 5 Year-6.47%
EPS past 5 Year-
Sales past 5 Year13.36%
EPS Y/Y-40.69%
Sales Y/Y6.02%
EPS Q/Q-96.06%
Sales Q/Q6.12%
Sales Surprise2.89%
EPS Surprise-24.09%
ATR(14)1.97
Perf Week-10.15%
Perf Month-21.94%
Perf Quarter-22.95%
Perf Year-42.57%
Perf YTD-43.82%
Target Price64.55

AryaFin Engine© - An AI FinTech Venture - 2024 Disclaimer